Navigation Links
Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
Date:2/12/2008

SAN DIEGO, Feb. 12 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Deutsche Bank Small- and Mid-Cap Growth Conference on Friday, February 15, 2008 at approximately 10 a.m. Eastern Time (7 a.m. Pacific Time). The presentation is scheduled to be webcast live and may be accessed through a link on Gen-Probe's website at http://www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertaintie
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
2. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
3. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
4. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
5. Webcast Alert: Kaiser Permanente Residency Program Open House
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
8. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
9. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
10. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
11. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Th...onsistent procedures to allow the public to,see ex...ished today in the,Federal Register http://edocke...will ensure that the best and latest available evi... risk assessments for health,standards regulating ...
(Date:8/29/2008)...iation may have caused chromosomal change that rai... FRIDAY, Aug. 29 (HealthDay News) -- Some Japanese...in Hiroshima and Nagasaki experienced key genetic ...of thyroid cancer, new research indicates. , Pa...o a particular genetic mutation involving the so-c...
(Date:8/29/2008)... LEEDS, England, August 29 /PRNewswire/ --, - MYA...ce for Recent,Big Brother Stars but the big Questi...as, mirrors all around and being on national,telev...ct on how you feel,about the way you look. For man... a reality. Upon leaving the house contestants may...
(Date:8/29/2008)... Dr. Milton Owens and the Co... Southern California to provide protection for cas...on, and the Hispanic community is benefiting. , ...ust 29, 2008 -- Dr. Milton Owens and the Coastal C...rn California to provide protection for cash payin...
Breaking Medicine News(10 mins):Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:MYA Makes Big Brother Stars Amazing! 2Health News:MYA Makes Big Brother Stars Amazing! 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2
... to a survey, mental health wards have been graded... mental health inpatients//. The charity called M...ction over the state of repair of their ward while...ndards of hygiene.Mind is for patients to be treat...
... a voluntary organization helping with the necessi...C), Thiruvananthapuram//. To mark its tenth anniv...ir on Wednesday. He handed over a copy of the souv...n.Mr. Bhatia, who applauded the services provided ...
...ients with schizophrenia whose medication is chang...cts, second-generation// antipsychotic drugs do no... first-generation antipsychotic drugs, according t...ves of General Psychiatry, one of the JAMA/Archive...
...has moles. Most of the time, they are nothing but ...ng cells in moles called melanocytes// start divid...r called melanoma. About one in 65 Americans born ...oma at some point during their lifetime. Scientist...
Other Medicine News:Health News:Mental Health Wards rated unpleasant 2Health News:A decade of service to cancer patients 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 3Health News:Why Don’t All Moles Progress to Melanoma 2Health News:Why Don’t All Moles Progress to Melanoma 3
(Date:8/26/2008)...e/ -- Omeros Corporation today announced the,publi... investigating,OMS103HP in arthroscopic anterior c...103HP is an investigational drug product that is a...signed to improve postoperative,knee function and ...ts an,earlier return to work. The article titled "...
(Date:8/25/2008)...n and Treatment Strategies--, PHILADELPHIA, Aug. ...overed gene mutations that are the main cause of t...blastoma. In addition, the researchers found,that ...-risk forms of,non-inherited neuroblastoma, the mo...nables us to offer the first genetic tests to fami...
(Date:8/25/2008)... calls it a ,miracle, LATHAM, N.Y., Aug. 25 /PRN...ided Radiation Therapy program at Community Care P... patients using RapidArc(TM),radiotherapy technolo...dvancement that delivers a highly-precise image-gu...tment in two minutes or less., RapidArc treatment...
(Date:8/25/2008)...etreatment and Japanese Development Studies ...mark, August 25 /- Genmab h...umab in chronic lymphocytic,leukemia and non-Hodgk...oday plans to begin four studies of,ofatumumab in ...non-Hodgkin,s lymphoma (NHL) this year., "Genmab ...
Breaking Medicine Technology:Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Thermage and Reliant Technologies to Join Forces 23310 1Thermage and Reliant Technologies to Join Forces 23310 2Thermage and Reliant Technologies to Join Forces 23310 3Thermage and Reliant Technologies to Join Forces 23310 4Thermage and Reliant Technologies to Join Forces 23310 5Thermage and Reliant Technologies to Join Forces 23310 6Thermage and Reliant Technologies to Join Forces 23310 7Angiotech to Establish Separate Operating and Royalty Businesses 6386 1Angiotech to Establish Separate Operating and Royalty Businesses 6386 2Angiotech to Establish Separate Operating and Royalty Businesses 6386 3Angiotech to Establish Separate Operating and Royalty Businesses 6386 4Angiotech to Establish Separate Operating and Royalty Businesses 6386 5Angiotech to Establish Separate Operating and Royalty Businesses 6386 6Angiotech to Establish Separate Operating and Royalty Businesses 6386 7Angiotech to Establish Separate Operating and Royalty Businesses 6386 8Angiotech to Establish Separate Operating and Royalty Businesses 6386 9Angiotech to Establish Separate Operating and Royalty Businesses 6386 10Angiotech to Establish Separate Operating and Royalty Businesses 6386 11Angiotech to Establish Separate Operating and Royalty Businesses 6386 12Angiotech to Establish Separate Operating and Royalty Businesses 6386 13Angiotech to Establish Separate Operating and Royalty Businesses 6386 14Edison Pharmaceuticals Receives Commendation From the City of San Jose 6382 1Edison Pharmaceuticals Receives Commendation From the City of San Jose 6382 2Newborn vitamin A reduces infant mortality 3904 1Newborn vitamin A reduces infant mortality 3904 2
...(CCNMatthews - June 14, 2007) - Ambrilia,Biopharma...oping,novel small molecules and peptides to treat ...neral and Special Meeting today, during,which the ...,integrase inhibitors and recent developments were...hairman of the Board, Mr. Frederic,Porte, and a pr...
...atient Trial Show Those Treated with Lumiracoxib,E...ressure Compared,to Ibuprofen, EAST HANOVER, N.J.,...arthritis who also have controlled hypertension ex... pressure when treated with,the investigational se...slight increase in those taking ibuprofen, a commo...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5
...nse Webster is the source for a complete line of d...mapping - all with the quality, reliability and pr...eader in catheter technology. All of our coronary ...tructed to help minimize the frustration and exces...
A-Focus I & II Catheters. A-Focus steerable atrial mapping catheter. Available in 10, 12, 14 and 20 electrode configurations. (Shown with 14 electrodes).
Mennen Medical offers patient monitoring products for hospital based settings requiring high acuity and medium acuity monitoring. The Envoy patient monitor is Mennens premier monitoring product. The
...IS PhysioLog Hemodynamic Monitoring and Data Manag...m for the cath lab, integrating complete functiona...m analysis , Data collection , Inventory contr... , Procedural reporting ,Data collection ...
Medicine Products: